logo
ProjectEnded

Whispering Gallery Modes (WGM) for label free bioanalytics

The status, timeline and source of this project. A free account opens every field.

Source: EU Funding & Tenders Portal

The latest industry research shows that about 90 percent of drugs that reach clinical stage fail due to incorrect selection methods. The same applies to diagnostic markers. A crucial failure source is the imperfect identification and characterisation of biological interaction analytics in the early stages of drug discovery and biomarker identification. Surflay's innovation addresses this challenge

Status
Closed
Location
Germany
Updated
22 Jul 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Whispering Gallery Modes (WGM) for label free bioanalytics

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Whispering Gallery Modes (WGM) for label free bioanalytics” is an infrastructure initiative, located in Germany. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

ended

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

The latest industry research shows that about 90 percent of drugs that reach clinical stage fail due to incorrect selection methods. The same applies to diagnostic markers. A crucial failure source is the imperfect identification and characterisation of biological interaction analytics in the early stages of drug discovery and biomarker identification. Surflay's innovation addresses this challenge. The company developed the unique WhisperSense technology based on the physical effect of whispering gallery modes (WGM). WhisperSense makes a full kinetic analysis of biological interations possible, uniquely applying a spatial resolution of up to 6 µm in complex biological matrixes (e.g. cell culture suspensions), also in a multiplex format. Furthermore and uniquely, it is possible to perform measurements in a wide variety of reaction vessels. For the first time, WhisperSense will allow full kinetic analyses within cell cultures and organoids. All these advances eliminate certain time consuming sample preparation steps at the customer's site and enable monitoring of running processes in real-time, leading to a more precise drug and biomarker selection. The development is protected by 3 patents and many years of expert knowledge in the production of the special spherical microparticles. Initially, Surflay will address the public sector with its WhisperSense technology, followed by the diagnostic and pharmaceutical industry.

Location

Country

Germany

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Article published date

2026-02-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project